Condition: Lung Cancer · Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
The investigators plan to conduct a multiomics analysis（such as, Genomics, proteomics, single cell RNA sequencing, space transcriptomics）of tumor tissue and blood, aiming at analyzing tumor heterogeneity, mapping the microenvironment map of lung cancer and exploring the mechanism of sensitivity and resistance to anti-PD1/PD-L1 antibodies.
This description comes directly from the study's public registry record.
Kai Wang, PhD · 13957158572 · doctorhuxi@163.com
Jiangnan Zhao, PhD · 18267098035 · zjn911016@126.com
Always discuss trial participation with your own doctor first.
| The Fourth Affiliated Hospital of Zhejiang University | Yiwu, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05636605